021-51111890
购物车（）
sales@molnova.cn
首页-
Products -
Others -
Other Targets -
Adrenocorticotropic Hormone (ACTH) (4-10) TFA(4037-01-8(free base))
Adrenocorticotropic Hormone (ACTH) (4-10) TFA(4037-01-8(free base))
CAS No. ——
Adrenocorticotropic Hormone (ACTH) (4-10) TFA(4037-01-8(free base)) ( Acth (4-10) )
产品货号. M22783 CAS No. ——
促肾上腺皮质激素 (ACTH) (4-10) 是一种有效的黑皮质素 (MC4R) 受体激动剂。在人类中，促肾上腺皮质激素 (ACTH) (4-10) 鼻内应用后进入脑液室，导致全身减少连续治疗6周后脂肪减少。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥744 | 有现货 |
|
| 5MG | ￥1052 | 有现货 |
|
| 10MG | ￥1756 | 有现货 |
|
| 25MG | ￥3493 | 有现货 |
|
| 50MG | ￥5349 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Adrenocorticotropic Hormone (ACTH) (4-10) TFA(4037-01-8(free base))
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述促肾上腺皮质激素 (ACTH) (4-10) 是一种有效的黑皮质素 (MC4R) 受体激动剂。在人类中，促肾上腺皮质激素 (ACTH) (4-10) 鼻内应用后进入脑液室，导致全身减少连续治疗6周后脂肪减少。
-
产品描述Adrenocorticotropic Hormone (ACTH) (4-10) is an agonist of potent melanocortin(MC4R) receptor .In humans, Adrenocorticotropic Hormone (ACTH) (4-10)?enters the cerebral fluid compartment after intranasal application and leads to a?decrease in total body fat after 6 weeks of continuous treatment.
-
体外实验——
-
体内实验——
-
同义词Acth (4-10)
-
通路Others
-
靶点Other Targets
-
受体melanocortin(MC4R)
-
研究领域——
-
适应症——
化学信息
-
CAS Number——
-
分子量962.09
-
分子式C44H59N13O10S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESOC(=O)C(F)(F)F.CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. P Wellh?ner, R H?rster, Jacobs F , et al. Intranasal application of the melanocortin 4 receptor agonist MSH/ACTH(4-10) in humans causes lipolysis in white adipose tissue.[J]. International Journal of Obesity, 2012, 36(5):703.
产品手册
关联产品
-
[Trp11]-Neurotensin
[Trp11]-Neurotensin
-
p-Phenylenediamine, ...
对苯二胺，N,N'-二苯基-是一种生物活性化学品。它已被用于预防羔羊维生素E缺乏症。
-
Monatepil maleate
Monatepil maleate (AJ-2615 maleate) is an orally active Ca2+-channel and α1-adrenoceptor antagonist and non-competitive heparanoyl-coenzyme A:cholesterol acyltransferase (ACAT) inhibitor with antihypertensive activity. Monatepil maleate is used in studies of hyperlipidemia and atherosclerosis. Monatepil maleate is used to study hyperlipidemia and atherosclerosis.
